Personalized Medicine Approach in Bladder Cancer Treatment: Genomic/Transcriptomic Analyses and Tumour Modelling
Bladder cancer is among the cancers with a high incidence both globally and in our country. The efficacy of chemotherapy in bladder cancer varies even among patients with the same diagnosis, type, grade, and histological stage.
Establishing of Cancer Mission Hubs: Networks and Synergies - ECHOS
In the field of cancer, healthcare services face challenges such as a lack of interaction among key stakeholders during the process from R&D to product.
Türkiye Cancer Institute 2025 Six-Month Unit Activity Report
Quality of Life in Oncology: measuring what matters for cancer patients and survivors in Europe – EuonQoL
Comparison and Validation of FDA-Approved Genomic Profiling Results in Cancer Patients with Domestic NGS Kit
Comparison and Validation of FDA-Approved Genomic Profiling Results in Cancer Patients with Domestic NGS Kit